Purpose To retrospectively evaluate the toxicity of concurrent weekly cisplatin and radiation
therapy (RT) for locally advanced cervical cancer. Materials and Methods Between April …

OBJECTIVES: The aim of this study was to evaluate the efficacy of postoperative nedaplatin-
based concurrent chemoradiotherapy (CCRT) in patients with FIGO stage IA2–IIB cervical …

PURPOSE To identify characteristics that predict response to chemotherapy in patients with
advanced or recurrent squamous cell carcinoma of the cervix. PATIENTS AND METHODS …

PURPOSE.: To explore clinical/pathologic factors associated with prognosis of patients with
locally advanced cervical carcinoma treated with weekly cisplatin and pelvic radiation …

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or
Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study - PMC Back to Top …

BACKGROUND.: One of the most active chemotherapy combinations in advanced or
recurrent cervical cancer is cisplatin–paclitaxel. However, this palliative regimen is …

Objective. The aim of this study was to assess the role of first-line chemotherapy with
paclitaxel and platinum in the treatment of advanced or recurrent cervix cancer. Methods …

Cervical cancer remains a major health problem worldwide, despite advances in screening.
For patients with locally advanced stage disease, failure to obtain local-regional control …

Purpose. Five recent phase III trials provide strong evidence that a new alternative therapy,
cisplatin-based chemoradiation, is more effective than standard therapy using radiation …

PURPOSE: To test the hypothesis that cisplatin (CDDP) administered concurrently with
standard radiotherapy (RT) would improve pelvic control and survival in patients with …